Literature DB >> 33264832

Improved adrenal vein sampling from a dedicated programme: experience of a low-volume single centre in Singapore.

Min-On Tan1, Troy Hai Kiat Puar2, Saravana Kumar Swaminathan1,3, Yu-Kwang Donovan Tay4, Tar Choon Aw5, David Yurui Lim1, Haiyuan Shi1, Lily Mae Quevedo Dacay2, Meifen Zhang2,6, Joan Joo Ching Khoo2, Keng Sin Ng1,7.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33264832      PMCID： PMC9251230          DOI： 10.11622/smedj.2020171

Source DB:  PubMed          Journal:  Singapore Med J        ISSN： 0037-5675            Impact factor:   3.331


× No keyword cloud information.
  32 in total

1.  Importance of contralateral aldosterone suppression during adrenal vein sampling in the subtype evaluation of primary aldosteronism.

Authors:  Hironobu Umakoshi; Kanako Tanase-Nakao; Norio Wada; Takamasa Ichijo; Masakatsu Sone; Nobuya Inagaki; Takuyuki Katabami; Kohei Kamemura; Yuichi Matsuda; Yuichi Fujii; Tatsuya Kai; Tomikazu Fukuoka; Ryuichi Sakamoto; Atsushi Ogo; Tomoko Suzuki; Mika Tsuiki; Akira Shimatsu; Mitsuhide Naruse
Journal:  Clin Endocrinol (Oxf)       Date:  2015-03-16       Impact factor: 3.478

2.  Adrenal vein sampling: is there now a consensus?

Authors:  Ellen Marie Freel
Journal:  Clin Endocrinol (Oxf)       Date:  2014-12-01       Impact factor: 3.478

3.  Successful Adrenal Venous Sampling by Non-experts with Reference to CT Images.

Authors:  Satoru Morita; Hiroshi Yamazaki; Yasuyuki Sonoyama; Yu Nishina; Atsuhiro Ichihara; Shuji Sakai
Journal:  Cardiovasc Intervent Radiol       Date:  2016-04-06       Impact factor: 2.740

Review 4.  Subtyping of Patients with Primary Aldosteronism: An Update.

Authors:  Jacques W M Lenders; Graeme Eisenhofer; Martin Reincke
Journal:  Horm Metab Res       Date:  2017-12-04       Impact factor: 2.936

5.  Type 2 diabetic patients with resistant hypertension should be screened for primary aldosteronism.

Authors:  J J Mukherjee; C M Khoo; A C Thai; S B Chionh; Lim Pin; K O Lee
Journal:  Diab Vasc Dis Res       Date:  2009-10-28       Impact factor: 3.291

6.  Visualization of right adrenal vein: Comparison with three phase dynamic contrast-enhanced CT.

Authors:  Yoshifumi Noda; Satoshi Goshima; Shoma Nagata; Hiroshi Kawada; Nobuyuki Kawai; Hiromi Koyasu; Masayuki Matsuo
Journal:  Eur J Radiol       Date:  2017-08-24       Impact factor: 3.528

Review 7.  The SPARTACUS Trial: Controversies and Unresolved Issues.

Authors:  Felix Beuschlein; Paolo Mulatero; Evelyn Asbach; Silvia Monticone; Cristiana Catena; Leonardo A Sechi; Michael Stowasser
Journal:  Horm Metab Res       Date:  2017-11-17       Impact factor: 2.936

8.  Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study.

Authors:  Gregory L Hundemer; Gary C Curhan; Nicholas Yozamp; Molin Wang; Anand Vaidya
Journal:  Lancet Diabetes Endocrinol       Date:  2017-11-09       Impact factor: 32.069

9.  Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort.

Authors:  Tracy A Williams; Jacques W M Lenders; Paolo Mulatero; Jacopo Burrello; Marietta Rottenkolber; Christian Adolf; Fumitoshi Satoh; Laurence Amar; Marcus Quinkler; Jaap Deinum; Felix Beuschlein; Kanako K Kitamoto; Uyen Pham; Ryo Morimoto; Hironobu Umakoshi; Aleksander Prejbisz; Tomaz Kocjan; Mitsuhide Naruse; Michael Stowasser; Tetsuo Nishikawa; William F Young; Celso E Gomez-Sanchez; John W Funder; Martin Reincke
Journal:  Lancet Diabetes Endocrinol       Date:  2017-05-30       Impact factor: 32.069

10.  Incidence of Atrial Fibrillation and Mineralocorticoid Receptor Activity in Patients With Medically and Surgically Treated Primary Aldosteronism.

Authors:  Gregory L Hundemer; Gary C Curhan; Nicholas Yozamp; Molin Wang; Anand Vaidya
Journal:  JAMA Cardiol       Date:  2018-08-01       Impact factor: 14.676
View more
  1 in total

1.  Treatment of Primary Aldosteronism and Reversal of Renin Suppression Improves Left Ventricular Systolic Function.

Authors:  Troy H Puar; Chin Kai Cheong; Roger S Y Foo; Seyed Ehsan Saffari; Tian Ming Tu; Min Ru Chee; Meifen Zhang; Keng Sin Ng; Kang Min Wong; Andrew Wong; Foo Cheong Ng; Tar Choon Aw; Joan Khoo; Linsey Gani; Thomas King; Wann Jia Loh; Shui Boon Soh; Vanessa Au; Tunn Lin Tay; Eberta Tan; Lily Mae; Jielin Yew; Yen Kheng Tan; Khim Leng Tong; Sheldon Lee; Siang Chew Chai
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-30       Impact factor: 6.055
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.